Stanley B. Kaye
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation
Most-Cited Works
- → A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer(2000)1,100 cited
- → Mechanisms of transcoelomic metastasis in ovarian cancer(2006)515 cited
- Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.(2000)
- → Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies(2005)488 cited
- → “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations(2008)471 cited
- → Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer(2010)404 cited
- → New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential(2013)372 cited
- → Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment(2004)331 cited
- → Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group(2001)279 cited
- → The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients(2004)261 cited